0:00 0:00 1x

This is read by an automated voice. Please report any issues or inconsistencies here .

AstraZeneca becomes second major pharmaceutical company to agree to lower Medicaid drug prices under Trump administration deal.

The agreement follows a similar Pfizer deal and a Trump executive order threatening tariffs if drugmakers didn’t voluntarily reduce costs for Americans.

WASHINGTON — AstraZeneca has become the second major pharmaceutical manufacturer to announce it has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration that avoided its threats of steep tariffs.

President Trump made the announcement in the Oval Office on Friday with AstraZeneca CEO Pascal Soriot, who said that during tough negotiations to reach a

See Full Page